How can smaller biopharma companies overcome the scale up and production complexities for microbial biomanufacturing?

What is going on with Aduhelm? And why is the drug seen by some to be controversial?

A microfluidic bioprocessing company has set up shop in central Scotland. We spoke to their CEO for an inside view.

An industry consortium is tackling one of pharma’s biggest drug-related challenges.

We want to hear your thoughts on what mRNA could do for cell and gene therapy

Are all antibiotics doomed to eventual impotence? New work from Oxford could change the game by defeating resistance itself.

Sitting Down With Dolores Schendel, Chief Executive Officer and Chief Scientific Officer at Medigene.

Get ready for medicine making level 2 as video games come to healthcare backed with clinical trial data that demonstrate efficacy.

Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March